Interview: Leonardo Vingiani – Director, ASSOBIOTEC, Italy
Leonardo Vingiani, Director of Assobiotec, discusses how the country’s biotech industry has evolved since 2009,…
Assobiotec
Last updated: 13.02.2014
Address: Via Giovanni da Procida 11, 20149 Milano,Italy
Tel: +39 02 34565306
Web: http://assobiotec.federchimica.it/
Company description
Set up in October 1986 within the Italian Federation of the Chemical Industry (Federchimica), Assobiotec is the Italian Association for the Development of Biotechnology, representing more than 120 companies and science & technology parks operating in Italy and involved in various biotech-related fields – pharmaceuticals, diagnostics, agro-food, fine chemicals, environment, processing industry and equipment. They include emerging biotech companies and small to medium enterprises, as well as the biotech divisions of large organisations.
Assobiotec is co-founder member of EuropaBio, the European Association for Bioindustries, created in 1996.
Assobiotec provides entrepreneurial support to Italian and EU biotech developments and is the landmark for Italian companies involved in production and marketing of products derived from biotech applications.
Assobiotec focuses its main attention on:
regulatory issues affecting production, marketing and use of biotechnology products and their standards harmonisation;
fiscal and financial policies aimed at motivating industrial innovation;
R&D, education and training projects and programmes.
Assobiotec’s policy is mainly dealing with:
monitoring legislation in the regulatory area;
representing Italian bioindustry at National and international level;
providing a regular forum for the exchange of information and initiatives of entrepreneurial relevance;
taking active part to the reviewing process concerning the rules on industrial property.
Assobiotec’s activities include:
close interaction with National and international trade organisations dealing with biotechnology;
regular contacts with Universities, fostering collaboration between academia and industry in research and education;
information services on commercial biotech applications, on patents and on R&D programmes implementation.
Products and services
Interviews
Interview with Leonardo Vingiani, General Director, Assobiotec
Biotechnologies have a significant role to play bringing Italy towards a more knowledge-based economy. What is the…
Related
Italy / Mandatory COVID-19 Vaccines for Healthcare Workers; Chiesi & Angelini’s AI Investments; Sputnik V Manufacturing
The latest from Italian pharma, including the government’s decision to make COVID-19 vaccines mandatory for all…
Italy / Stevanato’s $5 bn valuation; Zolgensma Approval; Sputnik V Manufacturing
The latest from Italian pharma, including the foreign minister’s plea for delivering on COVID-19 vaccine…
Italy / Menarini CEO on Averting Future Health Crises; Alfasigma Hackathon; January COVID Vaccines
A roundup of some of the most important recent stories from Italian pharma, including an in-depth interview with…
Pricing / Italy Takes Global Transparency Lead by Forcing Pharma to Disclose Public R&D Funding
In July 2020, Italy became the first country in the world to mandate pharma companies to disclose data surrounding…
News Roundup / Italy Pharma July 2020
Below we present recent news from Italy’s biopharma industry, including the recent acquisition of Stemline…
M&A / Menarini Makes Big US Oncology Move with Stemline Acquisition
Menarini Group, the largest Italian pharmaceutical company by turnover, has made its first move into the US…
Internationalization / Chiesi Moves into Rare Diseases & the US Market
Italian mid-cap firm Chiesi is continuing its expansion in the USA market with the launch of a Boston-based…
Interview: Luca G. Guidotti – Deputy Scientific Director, San Raffaele…
Prof. Luca G. Guidotti discusses the esteemed positioning of San Raffaele within the global scientific community,…
Interview: Gianvito Martino – Scientific Director & Director of the…
The division of neuroscience at the San Raffaele Scientific Institute is one of the best worldwide performers in…
Interview: Angelo Corti – Director, Division of Experimental Oncology, San…
Professor Angelo Corti, Director of the Experimental Oncology division of the SRSI, discusses approaches to…
Interview: Paola Pozzi – Head, Office of Biotechnology Transfer, San…
Dr. Paola Pozzi, the head of the Office of Biotechnology Transfer at the San Raffaele Scientific Institute,…
Italian Pharma SMEs: Family Knows Best!
Italy’s traditional family-owned pharmaceutical companies are one of its greatest strengths; but these companies…
